Health Law Policy

Mini-conference on antibiotic incentives

By Kevin Outterson If you will be in DC on Thursday, we have a great meeting about economic incentives for antibiotic innovation. Location is Capitol Hill. Register here. Panelists include Rep. Peter Roskam (House Ways & Means), Sir Jim O’Neill, head of the UK AMR Review, Dr. Susan Coller Monarez, National Security Council and Christine Ardal, coordinator…

Published:

By Kevin Outterson

If you will be in DC on Thursday, we have a great meeting about economic incentives for antibiotic innovation. Location is Capitol Hill. Register here.

Panelists include Rep. Peter Roskam (House Ways & Means), Sir Jim O’Neill, head of the UK AMR Review, Dr. Susan Coller Monarez, National Security Council and Christine Ardal, coordinator of WP2 (economic incentives) in DRIVE-AB.  I will present the first look at the long-awaited Chatham House report.

@koutterson

 

About the author

  • Kevin Outterson

    Kevin Outterson has served as a guest blogger on Bill of Health. Kevin teaches health law and corporate law at Boston University, where he co-directs the Health Law Program. He serves as Editor-in-Chief of the Journal of Law, Medicine & Ethics; faculty co-advisor to the American Journal of Law & Medicine; immediate past chair of the Section on Law, Medicine & Health Care of the AALS; and a member of the Board of the American Society of Law, Medicine & Ethics. Before teaching, Kevin was a partner at two major US law firms.

    More from Kevin